Frankfurt - Delayed Quote • EUR
Anavex Life Sciences Corp. (12X1.F)
As of 8:13 AM GMT+2. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | 12X1.F | S&P 500 |
---|---|---|
YTD | -64.41% | +7.19% |
1-Year | -56.38% | +25.57% |
3-Year | -68.77% | +22.31% |